Istituto Superiore di Sanità

Istituto Superiore di Sanità
Name	Istituto Superiore di Sanità
Caption	Headquarters in Rome
Established	21 April 1934
Founder	Benito Mussolini
Director	Rocco Bellantone
Staff	~2,000
Field	Public health, Biomedical research
Address	Viale Regina Elena, 299, Rome
Website	www.iss.it

Istituto Superiore di Sanità. It is the leading technical-scientific body of the Italian National Health Service, operating under the supervision of the Ministry of Health (Italy). Founded in the 1930s, it serves as Italy's principal institute for research, control, and consultation in the fields of public health, biomedical science, and healthcare. Its work encompasses disease prevention, epidemiological surveillance, risk assessment, and the formulation of evidence-based health policies for the protection of the nation's population.

History

The institute was established by royal decree on April 21, 1934, under the fascist government of Benito Mussolini, with the initial aim of centralizing hygiene and public health services. Its first director was the prominent physician Giovanni Battista Grassi, a renowned parasitologist. Early activities focused on combating endemic diseases like malaria and tuberculosis, and it rapidly became a center for the production of vaccines and serums. Following World War II, it was instrumental in the reconstruction of Italy's health infrastructure and played a key role during the 1957 influenza pandemic. Throughout the late 20th century, it expanded its mandate to address emerging challenges such as HIV/AIDS, cancer research, and environmental pollution.

Organization and structure

The institute is headquartered in a complex on Viale Regina Elena in Rome, near the Sapienza University of Rome. It is organized into numerous national centers, departments, and reference laboratories, each specializing in specific areas of health. Key structural components include the National Center for Global Health, the National Center for Disease Prevention and Health Promotion, and the National Center for Drug Research and Evaluation. Governance is led by a President and a Director General, currently Rocco Bellantone, who oversees a workforce of approximately 2,000 employees, including researchers, technicians, and public health experts. It maintains close operational ties with regional health authorities and other research bodies like the Italian National Research Council.

Research and activities

Core research spans a vast array of disciplines including infectious diseases, oncology, neuroscience, genetics, and environmental health. The institute operates advanced laboratories for genomic sequencing, toxicology testing, and pharmacovigilance. It conducts pivotal studies on vaccine safety and efficacy, antimicrobial resistance, and non-communicable diseases. A significant part of its work involves the evaluation and authorization of pharmaceuticals and medical devices for the Italian market. It also hosts the National HIV/AIDS Research Center, contributing to international efforts against the pandemic.

Public health functions

As the national hub for public health, it manages the epidemiological surveillance system for notifiable diseases, issuing regular bulletins and alerts. It provides technical guidance during health emergencies, such as the COVID-19 pandemic in Italy, where it coordinated testing protocols and data analysis. The institute assesses risks from chemical substances, air pollution, and food safety hazards, advising the Ministry of Health (Italy) and the European Food Safety Authority. It also sets national guidelines for clinical practice, prevention programs, and health promotion campaigns targeting issues like smoking cessation and vaccination coverage.

International collaboration

The institute is deeply integrated into the global health architecture, serving as a collaborating center for the World Health Organization in several domains, including nutrition and chemical safety. It actively participates in projects funded by the European Union through frameworks like Horizon Europe and the European Centre for Disease Prevention and Control. It partners with major international agencies such as the Centers for Disease Control and Prevention and the International Agency for Research on Cancer. These collaborations focus on global health security, capacity building in developing countries, and joint research initiatives on transboundary health threats.

Notable scientists and directors

Throughout its history, the institute has been associated with many distinguished figures. Early leaders included Giovanni Battista Grassi and Giuseppe Levi. Notable researchers have encompassed Daniel Bovet, who won the Nobel Prize in Physiology or Medicine for his work on antihistamines, and Rita Levi-Montalcini, another Nobel laureate renowned for her discovery of nerve growth factor. More recent influential directors include Enrico Garaci, who led during the SARS outbreak, and Walter Ricciardi, a key figure in health policy. The current director, Rocco Bellantone, a noted surgeon, continues this legacy of scientific leadership.

Category:Medical and health organizations based in Italy Category:Research institutes in Italy Category:Public health organizations